Screener
BioMarin Pharmaceuticals BMRN Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
| ASSETS | June 30, 2026 / (unaudited) | December 31, 2025 ⁽¹⁾ |
|---|---|---|
| Goodwill | 655,745 | 196,199 |
| Deferred tax assets | 888,575 | 1,508,697 |
| Other assets | 338,138 | 277,049 |
| Total assets | $11,723,442 | $7,594,022 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable and accrued liabilities | $1,005,793 | $759,031 |
| Current portion of long-term debt, net | 658,203 | — |
Item 1. Financial Statements
FAQ
- What is BioMarin Pharmaceuticals's total assets?
- BioMarin Pharmaceuticals (BMRN) reported total assets of $11.72B in Q2 2026.
- How has BioMarin Pharmaceuticals's total assets changed year-over-year?
- BioMarin Pharmaceuticals's total assets increased by 57.2% year-over-year, from $7.46B to $11.72B.
- What is the long-term trend for BioMarin Pharmaceuticals's total assets?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's total assets has grown at a 5.4% compound annual growth rate (CAGR), from $5.85B to $7.59B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about BioMarin Pharmaceuticals's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude